OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

事件进展（1 篇报道）

1. 2026-10-20 08:00
   OpenAI Blog OpenAI acquires Orchestra Bio

← 返回首页